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One of the main problems is that not everyone is sure exactly what is included in the definition of a "medical device". This term covers any product, other than a medicine, that is used in the healthcare environment for the diagnosis, treatment, prevention or monitoring of illness or disease, or alleviation of a handicap. It, therefore, encompasses a huge variety of products (it has been estimated that there are somewhere in the region of almost 90,000 devices available on the market) ranging from needles and syringes, to anaesthetic machines, central venous lines, patient monitors and vaporisers to name just a few.
The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health, formed by the merger of the Medical Devices Agency and the Medicines Control Agency which, on the devices side, is entrusted with safeguarding public health by working with clinicians, regulators and manufacturers to ensure that all medical devices used in the Health Service meet appropriate standards of safety, quality and performance and comply with provisions of the European Medical Devices Directives.
One of the Agency's main functions in carrying out this aim, is its management of an Adverse Incident Centre which currently receives almost 9,000 device related adverse incidents each year. Each incident is investigated on a priority scale, determined after discussion with the reporter and any relevant clinical or technical staff involved. Investigations may result in a number of actions being taken, including the issuing of advice to the Health Service by means of a Device Alert, or working with manufacturers to prevent recurrence of a problem through modification or recall of a device. As a result of adverse incidents reported last year, 72 Device Alerts were issued, covering advice on a wide range of subjects, including overfilling of anaesthetic vaporisers, entrapment of anaesthetic breathing systems between operating tables and patient trolleys, prevention of hypoxic gas mixtures, issues relating to heat and moisture exchangers and filters and a variety of concerns involving infusion pumps. Additionally, there were over 400 product recalls or field corrections involving MHRA's supervision or active involvement, 260 cases requiring the provision of advice on safer device use or improved staff training by MHRA and, in 740 cases, manufacturers undertook to improve designs, manufacturing processes or quality systems, directly as a result of the conclusions from MHRA investigations.
Although the Adverse Incident Centre receives a number of device-related adverse incident reports directly from manufacturers, these relate mainly to problems arising from shortcomings in the device or its instructions for use. Increasingly, we know that adverse incidents also occur as a result of user practices, conditions of use, inappropriate storage or maintenance, or difficulties with cleaning, decontamination or sterilisation. If improvements are to be made in design, function, materials, ergonomics and instructions for use, therefore, it is vital that the Agency continues to receive reports directly from users who have experience with the device. We, therefore, urge you to let us know of any device related adverse event, however apparently trivial, since we have many examples of MHRA being the first globally to identify problems, mainly as a result of user reporting. It could not be easier. These reports can be made by the MHRA website (www.mhra.gov.uk), which will enable the reporter to receive an automatic acknowledgement and a unique reference number. Alternatively, a standard user report form can be downloaded from the website and e-mailed to the Adverse Incident Centre (AIC) (aic@mhra.gsi.gov.uk), faxed to AIC on 020 7084 3109, or posted to: 
